HealthLynked Names George O'Leary Interim CFO, Eliminates COO Role Amid Nasdaq Uplisting Push
HLYK has more than doubled off its 52-week low of $1.06 on elevated volume (3.3× avg).
Summary
HealthLynked appointed George O'Leary as part-time Interim CFO and eliminated the COO position, restructuring leadership to support a Nasdaq uplisting and a planned $7.5 million capital raise.
Key Events · Executive and Board Changes · HLYK
-
Interim CFO Appointed
Effective July 13, 2026, George O'Leary—a director and former CFO—was appointed part-time Interim CFO, earning $15,000 per month plus 35,000 options that vest only upon Nasdaq listing approval.
-
CFO Transitioned Out
Jeremy Daniel ceased serving as CFO and moved to a corporate accounting role; no disagreement was cited.
-
COO Position Eliminated
The COO role is being eliminated, and Duncan McGillivray will depart on July 24, 2026, transitioning to Senior Strategic Advisor on an as-needed basis.
-
Nasdaq Uplisting and Financing Goal
O'Leary's primary mandate is to secure a Nasdaq Capital Market listing and assist in a planned $7.5 million institutional equity financing post-approval.
Analysis · HLYK · Industrial Applications And Services
In a race toward a Nasdaq uplisting, HealthLynked is overhauling its executive team. The company brought back former CFO George O'Leary on a part-time basis, paying him $15,000 monthly plus 35,000 options that vest only if Nasdaq approves the listing. Simultaneously, it pushed out the sitting CFO and eliminated the COO role entirely. The moves signal a last-ditch effort to cut costs and install a finance chief with capital markets experience to execute the $7.5 million institutional financing planned after a potential Nasdaq approval. With a going concern warning and dwindling cash, the restructuring is a high-stakes bet that O'Leary can deliver the listing and the capital raise before the company runs out of runway.
How filings like this one have moved
In the 30 days to Oct 3, 2026, 28.9% of the 1668 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HLYK was trading at $2.95 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $8.7M. The 52-week trading range was $1.06 to $6.50. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.